Research map: Loss of SATB2 is associated with MUC16 upregulation in the invasive component of colitis-associated colorectal carcinoma

Back to the article

Papers in this map

  1. Reactivity of a monoclonal antibody with human ovarian carcinoma. · Robert C. Bast · 1981 · 1683 citations · Cited by this paper
  2. Clinicopathological analysis of 21 cases of “Synchronous” endocervical and ovarian adenocarcinomas · 2026 · Related
  3. Molecular Cloning of the CA125 Ovarian Cancer Antigen · Beatrice W.T. Yin · 2001 · 661 citations · Cited by this paper
  4. Combined inverted follicular keratosis and adnexal tumors: a series of 12 cases · 2026 · Related
  5. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress · Mildred A. R. Felder · 2014 · 567 citations · Cited by this paper
  6. Clinicopathological features and risk stratification for lymph node metastasis in early-stage colorectal cancer (from intramucosal carcinoma to SM2): a large-scale retrospective study based on a Chinese population · 2026 · Related
  7. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease · Maurice W. M. D. Lutgens · 2013 · 529 citations · Cited by this paper
  8. High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images · 2026 · Related
  9. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study · Ola Olén · 2020 · 475 citations · Cited by this paper
  10. ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases · 2026 · Related
  11. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers · Ana I. Robles · 2016 · 274 citations · Cited by this paper
  12. MYD88L265P mutation is a highly specific marker for the nonGCB/ABC DLBCL molecular subtype · 2026 · Related
  13. Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis · Carlos Castaño-Milla · 2014 · 268 citations · Cited by this paper
  14. Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma · 2026 · Related
  15. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease · Rona D. Yaeger · 2016 · 202 citations · Cited by this paper
  16. GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterations · 2026 · Related
  17. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells · Imayavaramban Lakshmanan · 2011 · 157 citations · Cited by this paper
  18. Sarcomatous transformation of an astrocytoma IDH-mutant following radiotherapy · 2026 · Related
  19. Colitis‐associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy · Mai Iwaya · 2021 · 37 citations · Cited by this paper
  20. Low-grade fibromyxoid sarcoma in abdominopelvic and retroperitoneal locations: a clinicopathologic analysis of 26 cases and a review of the literature · 2026 · Related
  21. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease–associated Colorectal Dysplasia and Adenocarcinoma · Changqing Ma · 2019 · 28 citations · Cited by this paper
  22. Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression · Mai Iwaya · 2019 · 27 citations · Cited by this paper
  23. Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2 · Zhining Liu · 2021 · 23 citations · Cited by this paper
  24. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery · Zeliang Xu · 2021 · 15 citations · Cited by this paper
  25. Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma · Maximilian N. Kinzler · 2022 · 12 citations · Cited by this paper
  26. Association Between Loss of SATB2 Expression in Inflammatory Bowel Disease Indefinite for Dysplasia and a Diagnosis of Definitive Dysplasia on Follow-up · Anthony Cretara · 2022 · 5 citations · Cited by this paper
  27. Mapping the Binding Sites of CA125-Specific Antibodies on a Revised Molecular Model of MUC16 · Chien-Wei Wang · 2025 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)